[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-358854-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-358854-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mechanism-of-asic4-in-regulating-mhc-i-mediated-immune-evasion-in-pancreatic-cancer","Mechanism of ASIC4 in regulating MHC-I-mediated immune evasion in pancreatic cancer","","Immune evasion drives poor therapeutic outcomes in pancreatic ductal adenocarcinoma (PDAC), yet the mechanism linking MHC-I downregulation to low cytotoxic T lymphocyte (CTL) infiltration remains unclear. This study identifies acid-sensing ion channel ASIC4 as a driver of reduced MHC-I expression and evaluates ASIC4 as a potential target. Bioinformatics, IHC, and mechanistic assays are integrated with an orthotopic PDAC mouse model to test effects on CD8+ T infiltration and tumor progression.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mechanism-of-asic4-in-regulating-mhc-i-mediated-immune-evasion-in-pancreatic-cancer/358854/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mechanism-of-asic4-in-regulating-mhc-i-mediated-immune-evasion-in-pancreatic-cancer/358854.png","ImageObject",300,407,{"name":42,"@type":43},"Miles","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of the study on ASIC4 and MHC-I in PDAC?","Question",{"text":63,"@type":64},"The study aims to determine the molecules responsible for low MHC-I expression and to identify potential novel therapeutic targets to reverse immune evasion in pancreatic cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is ASIC4 connected to immune evasion in pancreatic ductal adenocarcinoma?",{"text":68,"@type":64},"ASIC4 expression is significantly upregulated in PDAC and negatively correlates with MHC-I expression, which is linked to poor prognosis and reduced infiltration of cytotoxic T lymphocytes.",{"name":70,"@type":61,"acceptedAnswer":71},"What experimental evidence shows that targeting ASIC4 affects tumor progression and immune cell infiltration?",{"text":72,"@type":64},"Knocking down ASIC4 increases CD8+ T cell infiltration and slows tumor growth in vivo, and mechanistic work indicates ASIC4 inhibition restores MHC-I total and surface levels by blocking its autophagic-lysosomal degradation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},358854,1790193362,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","An etal. Journal of Translational Medicine (2026) 24:304  \n[https://doi.org/10.1186/s12967-026-07880-1](https://doi.org/10.1186/s12967-026-07880-1)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nMechanism of ASIC4 in regulating MHC-Imediated immune evasion in pancreatic cancer  \nQi An1, Zhongwu An1, Weibo Bo1, Chaochun Yan1, Nan Sun1, Jianxin Ma1*, Jianye Li1* and Wenjuan Wang1*  \nAbstract  \nBackground Immune evasion is a major cause of the poor efficacy of therapies for pancreatic ductaladenocarcinoma (PDAC) . However, the underlying mechanism by which MHC-I downregulation leads to low infiltration of cytotoxic T lymphocytes in PDAC remains incompletely elucidated. This study aims to identify the molecules responsible for the low expression of MHC-I and potential novel therapeutic targets, thereby providing a theoretical foundation for reversing immune evasion in pancreatic cancer.  \nMethods Bioinformatic analysis identified the acid-sensing ion channel (ASIC4) as a key factor associated with low cytotoxic T lymphocyte (CTL) infiltration in pancreatic ductal adenocarcinoma (PDAC) . The correlation between ASIC4 expression and patient prognosis was analyzed via immunohistochemistry (IHC) . To elucidate the molecular mechanism by which ASIC4 mediates immune evasion in PDAC, we comprehensively utilized Western blotting, co-immunoprecipitation, and immunofluorescence. An orthotopic PDAC mouse model was established to assess the impact of ASIC4 deletion on CD8⁺ T cell infiltration and tumor growth in vivo.  \nResults The study found that in pancreatic ductal adenocarcinoma (PDAC), the expression of ASIC4 was significantly upregulated and negatively correlated with the low expression of Major Histocompatibility Complex class I (MHCI), which was associated with poor patient prognosis. Notably, knocking down ASIC4 led to a significant increase in CD8+ T cell infiltration and slowed tumor growth in vivo. Mechanistic investigations revealed that ASIC4 knockdown restored total and surface levels of MHC-I by inhibiting its autophagic-lysosomal degradation.  \nConclusion This study revealed that ASIC4 is highly expressed in PDAC, and its elevated expression is significantly associated with poor prognosis in pancreatic cancer patients. Further mechanistic investigations demonstrated that ASIC4 promotes the degradation of MHC-I via the lysosomal pathway. The subsequent reduction in MHC-I expression leads to decreased infiltration of cytotoxic T lymphocytes (CTLs), ultimately accelerating pancreatic cancer progression. Silencing ASIC1 restored MHC-I expression and enhanced the antitumor efficacy of CD8⁺ T cells.  \n*Correspondence: Jianxin Ma[mjx3416@163.com](mjx3416@163.com)[ ](mjx3416@163.com)Jianye Li[lijianye02101@sina.com](lijianye02101@sina.com)[ ](lijianye02101@sina.com)Wenjuan Wang [18352823278@163.com](18352823278@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licens","cbCaigyIr8bJpNmt","https://ap.wps.com/l/cbCaigyIr8bJpNmt","pdf",3321241,18,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusion\n# Introduction","[{\"question\":\"What is the main purpose of the study on ASIC4 and MHC-I in PDAC?\",\"answer\":\"The study aims to determine the molecules responsible for low MHC-I expression and to identify potential novel therapeutic targets to reverse immune evasion in pancreatic cancer.\"},{\"question\":\"How is ASIC4 connected to immune evasion in pancreatic ductal adenocarcinoma?\",\"answer\":\"ASIC4 expression is significantly upregulated in PDAC and negatively correlates with MHC-I expression, which is linked to poor prognosis and reduced infiltration of cytotoxic T lymphocytes.\"},{\"question\":\"What experimental evidence shows that targeting ASIC4 affects tumor progression and immune cell infiltration?\",\"answer\":\"Knocking down ASIC4 increases CD8+ T cell infiltration and slows tumor growth in vivo, and mechanistic work indicates ASIC4 inhibition restores MHC-I total and surface levels by blocking its autophagic-lysosomal degradation.\"}]","Mechanism of ASIC4 in regulating MHC-I-mediated immune evasion in pancreatic cancer | PDF",1790135474,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8857afb9c35ac0af6773b336af3a08b9.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f3a5439be07af3eb5675ed5abc24230.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f56c551a87160003992e2a414e69cd0a.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e399bf2b18b305a5c1c1373740e0012b.webp",980,1306]